accountInc. for $21.3 billion. The deal would be the biggest in J&J���s 125-year history. The anticipated drug approvals are ���a signal that things are improving��� for a pharmaceutical unit that has seen sales slide 3.7 percent since 2006 amid competition...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to J&J AIDS Pill Signals $9 Billion in Sales to Ease Recall Woes
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account